Navigation Links
DAVISCO Foods International, Inc. and MEGGLE Group Announce a Joint Venture for the Production of Pharmaceutical Lactose.
Date:11/16/2009

EDEN PRAIRIE, Minn., Nov. 16 /PRNewswire/ -- Announced on November 06, 2009 by Mr. Mark Davis, the President and CEO of DAVISCO Foods International Inc., and the Board of MEGGLE Group of Wasserburg, Germany, represented by Drs Sil H. van der Ploeg, CEO, and Mr. Christian Sedlatschek, CFO, the companies are entering a long-term partnership for the production of pharmaceutical lactose in the United States.

DAVISCO Foods is an international cheese and food ingredient company, founded in 1943, headquartered in Le Sueur, MN., a privately-held, family-owned business. DAVISCO is a company committed to technical advancement, customer service, and the production of superior quality products.

The holding group MEGGLE AG, whose headquarters are in Wasserburg, Germany was founded in 1887 and bundles the activities of the different companies within the milk and whey-processing business group. This structure embodies flexibility and decisiveness on the one hand and the traditional character of the dairy with its long history of milk-processing on the other. The Business Group Excipients & Technology is considered the leading producer of pharmaceutical lactose and excels in particular in offering High - Tech, innovative excipients to the pharmaceutical industry worldwide.

DAVISCO will expand their existing lactose production at the Le Sueur facility to accommodate additional production lines for the production of pharmaceutical lactose utilizing state-of-the-art processing technology.

MEGGLE will provide the technical marketing, sales and distribution for the pharmaceutical lactose products.

"DAVISCO Foods Intl. Inc. is excited and honored to engage in a joint venture with the MEGGLE Company to produce pharmaceutical lactose products. We have had a close and rewarding relationship for years with MEGGLE and have respected and admired their many achievements. The joint venture will produce the same high quality products and provide the same service that MEGGLE has historically produced and provided." Mr. Mark Davis, President DAVISCO Food International Inc.

"MEGGLE highly appreciates the partnership with DAVISCO. This is an important step in our strategy to expand our capacities and at the same time to offer our customers worldwide the security of a second production site." Drs Sil H. van der Ploeg, CEO of MEGGLE

www.DAVISCOFoods.com

www.MEGGLE.com

SOURCE DAVISCO Foods International, Inc.


'/>"/>
SOURCE DAVISCO Foods International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Soyfoods Do Not Impact Sperm Count
2. New Database from ANSI, AAMI, ASTM International, and DIN Provides Centralized Source of Information for Medical Device Professionals
3. Natural Alternatives International, Inc. Announces Filing of Patent Infringement Lawsuit
4. Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results
5. Chindex International, Inc. to Report Second Quarter Fiscal 2010 Financial Results
6. Medizone International, Inc. (MZEI.PK): Trials of the AsepticSure Hospital Sterilization System Have Begun
7. Arno Therapeutics, Inc. Completes $18 Million Financing and Reverse Merger with Laurier International, Inc.
8. Encorium Group, Inc. Appoints Sari Laitinen to Board of Directors
9. WellTek/MedX Group Completes Major Reorganization
10. Hill-Rom and Encompass Group Form Joint Venture
11. GSI Group Inc. Announces NASDAQ Delisting and Reports Progress on Revenue Recognition Review and Preliminary Third Quarter 2009 Bookings and Cash Balance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2017)... 2017 Zymo Research Corp., also known as ,The Epigenetics Company, ... aging in a precise manner using the myDNAge ™ test. Based ... professor of human genetics and biostatistics at the David Geffen School ... , Zymo Research,s proprietary DNAge ™ technology is used to analyze ... ...
(Date:7/11/2017)... JERUSALEM , July 11, 2017 Oramed ... ), a clinical-stage pharmaceutical company focused on the development ... U.S. Food and Drug Administration (FDA) has agreed to ... successfully completed Phase IIb trial of its oral insulin ... The Phase IIb trial met primary and secondary endpoints ...
(Date:7/10/2017)... , July 10, 2017 Locus Biosciences ... Note to support the development of CRISPR-Cas3 antimicrobial therapeutics. ... Limited, a leading Chinese Internet services provider, and joined ... advance multiple infectious disease product programs targeting antibiotic resistant ... Founded by Dr. Rodolphe Barrangou ...
Breaking Medicine Technology:
(Date:7/27/2017)... ... July 27, 2017 , ... Standard Process is ushering in a new era ... North Carolina Research Campus (NCRC) in Kannapolis, North Carolina and by announcing a new ... fall of this year, occupying over 10,000 square feet on the first floor of ...
(Date:7/27/2017)... ... 2017 , ... For bicycling enthusiasts around the globe, Germany's famous Rad am ... against a backdrop of tree-lined hills at the Nürburgring, a Formula One arena known ... Ring consists of some 73 curves, stretching out over more than 500 meters of ...
(Date:7/27/2017)... (PRWEB) , ... July 28, 2017 , ... ... Syngenta on an upcoming episode of the award-winning television series, American Famer, scheduled ... on RFD-TV. , Syngenta is dedicated to helping humanity face its toughest ...
(Date:7/27/2017)... OH (PRWEB) , ... July 27, 2017 , ... ... Electronic Visit Verification to State Medicaid programs, Managed Care Organizations and Home Care ... 2017. , The MEDsys platform, VinCENT, provides technology solutions to over 1,000 agencies ...
(Date:7/27/2017)... ... 2017 , ... GAFFEY Healthcare, a leading provider of revenue ... Vice President of Revenue Cycle Business Services and Suzanne Dusak to Vice President ... officer (CEO). , Elrene has been with company since Oct 2014 and previously ...
Breaking Medicine News(10 mins):